{
  "id": 17497753,
  "title": "After Eli Lilly’s Explosive Earnings Report, Is It Too Late to Buy the Stock?",
  "url": "https://urgent.news/2026/10/31/after-eli-lillys-explosive-earnings-report-is-it-too-late-to-buy-the-17497753",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-31T22:30:02.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/after-eli-lillys-explosive-earnings-report-it-too-late-buy-stock"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsEli Lilly dominates the weight loss drug market and has a strong pipeline that may produce future winners.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "After Eli Lilly’s Explosive Earnings Report, Is It Too Late to Buy the Stock?",
        "url": "https://urgent.news/2026/10/31/after-eli-lillys-explosive-earnings-report-is-it-too-late-to-buy-the",
        "published": "2026-10-31T22:10:02.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}